Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension
(2026) In American Heart Journal Plus: Cardiology Research and Practice 71.- Abstract
- Background
The aim of this study was to investigate associations between 92 proteins and blood pressure (BP), prevalent hypertension (HT) and apparent treatment-resistant HT (aTRH) in a population-derived sub cohort.
Methods
Excluding subjects with atherosclerotic cardiovascular disease (ASCVD) (n = 189), linear regression models assessed associations between proteins and systolic BP. Proteins showing significant associations (false discovery rate 5%) with systolic BP were analysed adjusting for clinically relevant covariates. Associated proteins were further analysed for associations with diastolic BP, prevalent HT, and aTRH, in multivariable regression models.
Results
Complete data was available in 1527... (More) - Background
The aim of this study was to investigate associations between 92 proteins and blood pressure (BP), prevalent hypertension (HT) and apparent treatment-resistant HT (aTRH) in a population-derived sub cohort.
Methods
Excluding subjects with atherosclerotic cardiovascular disease (ASCVD) (n = 189), linear regression models assessed associations between proteins and systolic BP. Proteins showing significant associations (false discovery rate 5%) with systolic BP were analysed adjusting for clinically relevant covariates. Associated proteins were further analysed for associations with diastolic BP, prevalent HT, and aTRH, in multivariable regression models.
Results
Complete data was available in 1527 individuals (mean age 67.1 ± 6.0 years; 30.5% women). Interleukin-1 receptor type 2 (IL1R2) associated with systolic BP (β 2.79, p 0.008), diastolic BP (β 1.78, p < 0.001), HT (odds ratio (OR), 1.34 [95% CI, 1.01–1.78]) and aTRH (OR, 1.94 [1.11–3.39]) while chitinase-3-like-protein 1 (CHI3L1) associated with systolic BP (β 1.53, p 0.004) and prevalent HT (OR 1.20, [1.04–1.38]). Pathway analysis suggested “metabolism of angiotensinogen to angiotensins”, “neutrophil degranulation” and “peptide hormone metabolism” as significantly enriched, in relation to blood pressure.
Conclusions
Among 1527 individuals without established ASCVD, IL1R2 was associated with systolic and diastolic blood pressure, as well as with both HT and aTRH, while CHI3L1 associated with systolic blood pressure and prevalent HT. These findings may offer novel insights and inspire future research on HT and inflammation. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/400a8cd3-5272-4a22-a5ec-01b290a6b35b
- author
- organization
-
- Cardiovascular Research - Hypertension (research group)
- MultiPark: Multidisciplinary research on neurodegenerative diseases
- EXODIAB: Excellence of Diabetes Research in Sweden
- EpiHealth: Epidemiology for Health
- Family Medicine and Community Medicine (research group)
- Internal Medicine - Epidemiology (research group)
- WCMM-Wallenberg Centre for Molecular Medicine
- publishing date
- 2026-11-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- American Heart Journal Plus: Cardiology Research and Practice
- volume
- 71
- article number
- 100937
- ISSN
- 2666-6022
- DOI
- 10.1016/j.ahjo.2026.100937
- language
- English
- LU publication?
- yes
- id
- 400a8cd3-5272-4a22-a5ec-01b290a6b35b
- alternative location
- https://linkinghub.elsevier.com/retrieve/pii/S2666602226002260
- date added to LUP
- 2026-10-08 13:34:33
- date last changed
- 2026-10-08 13:37:29
@article{400a8cd3-5272-4a22-a5ec-01b290a6b35b,
abstract = {{Background<br/>The aim of this study was to investigate associations between 92 proteins and blood pressure (BP), prevalent hypertension (HT) and apparent treatment-resistant HT (aTRH) in a population-derived sub cohort.<br/><br/>Methods<br/>Excluding subjects with atherosclerotic cardiovascular disease (ASCVD) (n = 189), linear regression models assessed associations between proteins and systolic BP. Proteins showing significant associations (false discovery rate 5%) with systolic BP were analysed adjusting for clinically relevant covariates. Associated proteins were further analysed for associations with diastolic BP, prevalent HT, and aTRH, in multivariable regression models.<br/><br/>Results<br/>Complete data was available in 1527 individuals (mean age 67.1 ± 6.0 years; 30.5% women). Interleukin-1 receptor type 2 (IL1R2) associated with systolic BP (β 2.79, p 0.008), diastolic BP (β 1.78, p < 0.001), HT (odds ratio (OR), 1.34 [95% CI, 1.01–1.78]) and aTRH (OR, 1.94 [1.11–3.39]) while chitinase-3-like-protein 1 (CHI3L1) associated with systolic BP (β 1.53, p 0.004) and prevalent HT (OR 1.20, [1.04–1.38]). Pathway analysis suggested “metabolism of angiotensinogen to angiotensins”, “neutrophil degranulation” and “peptide hormone metabolism” as significantly enriched, in relation to blood pressure.<br/><br/>Conclusions<br/>Among 1527 individuals without established ASCVD, IL1R2 was associated with systolic and diastolic blood pressure, as well as with both HT and aTRH, while CHI3L1 associated with systolic blood pressure and prevalent HT. These findings may offer novel insights and inspire future research on HT and inflammation.}},
author = {{Dieden, Anna and Melander, Olle and Pareek, Manan and Råstam, Lennart and Lindblad, Ulf and Gudmundsson, Petri and Daka, Bledar and Leósdóttir, Margrét and Nilsson, Peter M. and Olsen, Michael H. and Jujic, Amra and Magnusson, Martin}},
issn = {{2666-6022}},
language = {{eng}},
month = {{11}},
series = {{American Heart Journal Plus: Cardiology Research and Practice}},
title = {{Proteomic markers associated with blood pressure, hypertension, and treatment-resistant hypertension}},
url = {{http://dx.doi.org/10.1016/j.ahjo.2026.100937}},
doi = {{10.1016/j.ahjo.2026.100937}},
volume = {{71}},
year = {{2026}},
}
